(Q36136206)

12 August 2017

A phase II study of tamoxifen plus melatonin in metastatic solid tumour patients (English)

1 reference

12 August 2017

1 reference

Lissoni P

1

1 reference

12 August 2017

Paolorossi F

2

1 reference

12 August 2017

Tancini G

3

1 reference

12 August 2017

Ardizzoia A

4

1 reference

12 August 2017

Barni S

5

1 reference

12 August 2017

Brivio F

6

1 reference

12 August 2017

Maestroni GJ

7

1 reference

12 August 2017

Chilelli M

8

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 November 1996

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

74

1 reference

12 August 2017

9

1 reference

12 August 2017

1466-1468

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1996.566

12 August 2017

0 references

cites work

Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074765

Cachectin: more than a tumor necrosis factor

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074765

Melatonin: a rediscovered antitumor hormone? Its relation to surface receptors; sex steroid metabolism, immunologic response, and chronobiologic factors in tumor growth and therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074765

Suppressor Cells in Neoplastic Disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074765

Pineal Melatonin, Its Fundamental Immunoregulatory Role in Aging and Cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074765

Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074765

Effect of tamoxifen on serum insulinlike growth factor I levels in stage I breast cancer patients

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074765

Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074765

Endocrine and immune effects of melatonin therapy in metastatic cancer patients

2 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8912546

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Clinical Results with the Pineal Hormone Melatonin in Advanced Cancer Resistant to Standard Antitumor Therapies

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8912546

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/BJC.1996.566

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

8912546

1 reference